Source: Cardiovascular Therapeutics. Unidades: HU, FCF
Subjects: DISLIPIDEMIAS, HIPERCOLESTEROLEMIA
ABNT
GUIMARÃES, Elizandra Silva et al. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, v. 35, n. 6, p. art. e12307 1-8, 2017Tradução . . Disponível em: https://doi.org/10.1111/1755-5922.12307. Acesso em: 28 ago. 2024.APA
Guimarães, E. S., Cerda, A., Dórea, E. L., Bernik, M. M. S., Gusukuma, M. C., Pinto, G. A., et al. (2017). Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, 35( 6), art. e12307 1-8. doi:10.1111/1755-5922.12307NLM
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1111/1755-5922.12307Vancouver
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1111/1755-5922.12307